CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






Ether, 2,2 - dichloro - 1,1 - difluoroethyl methyl

RTECS #: KN7820000

CAS #: 76-38-0


UPDATE: May 2009 MW: 164.97 MF: C3H4Cl2F2O


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. SKIN AND EYE IRRITATION DATA:
  3. MUTATION DATA:
  4. REPRODUCTIVE EFFECTS DATA:
  5. ACUTE TOXICITY DATA:
  6. OTHER MULTIPLE DOSE DATA:
  7. REVIEWS:
  8. STANDARDS AND REGULATIONS:
  9. NIOSH DOCUMENTATION AND SURVEILLANCE:
  10. STATUS IN FEDERAL AGENCIES:
  11. REFERENCES:

SYNONYMS:

  1. 2,2 - Dichloro - 1,1 - difluoroethyl methyl ether
  2. Analgizer
  3. Anecotan
  4. Ethane, 2,2 - dichloro - 1,1 - difluoro - 1 - methoxy -
  5. Ingalan
  6. Inhalan
  7. Methoflurane
  8. Methoxane
  9. Methoxyfluran
  1. Methoxyflurane
  2. Metofane
  3. Metoxfluran
  4. Metoxifluran
  5. NSC - 110432
  6. Penthrane
  7. Pentran
  8. Pentrane


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
eye
rabbit
100 mg moderate FEPRA7 35,729,1976


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
cytogenetic analysis parenteral
chicken
10 mg ENVRAL 12,366,1976
cytogenetic analysis human lymphocyte 200 ppm/24 hour ENVRAL 12,366,1976
cytogenetic analysis mouse fibroblast 100 ppm ENVRAL 12,366,1976
other mutation test systems hamster fibroblast 1 pph ANESAV 43,21,1975
other mutation test systems inhalation
rat
5,000 ppm/3 hour- continuous EXPEAM 35,71,1979


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
inhalation
mouse
lowest published toxic concentration: 2 ppm/4 hour (6-15 day pregnant) Reproductive: Specific developmental abnormalities: Urogenital system AACRAT 59,421,1980
inhalation
mouse
lowest published toxic concentration: 2,000 ppm/4 hour (6-15 day pregnant) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)

Reproductive: Specific developmental abnormalities: Musculoskeletal system
AACRAT 59,421,1980
inhalation
rat
lowest published toxic concentration: 100 ppm/8 hour (1-21 day pregnant) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) ANESAV 48,11,1978
inhalation
rat
lowest published toxic concentration: 400 ppm/8 hour (1-21 day pregnant) Reproductive: Specific developmental abnormalities: Musculoskeletal system ANESAV 48,11,1978


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
inhalation
dog
lowest published toxic concentration: 3 pph Lung, Thorax, or Respiration: Other changes

Liver: Fatty liver degeneration

Endocrine: Hyperglycemia
VCVGK* -,286,1994
inhalation
human
lowest published toxic concentration: 3,500 ppm/1 hour Kidney, Ureter, and Bladder: Renal function tests depressed CANJAE 21,294,1974
inhalation
mammal (species unspecified)
lethal concentration (50 percent kill): 34 gm/m3 Behavioral: Antipsychotic GTPZAB 24(4),55,1980
inhalation
mouse
lethal concentration (50 percent kill): 21,500 mg/m3 Behavioral: General anesthetic

Behavioral: Somnolence (general depressed activity)

Behavioral: Excitement
GTPZAB 22(7),55,1978
inhalation
mouse
lethal concentration (50 percent kill): 122,600 mg/m3/4 hour N/R VCVGK* -,286,1994
inhalation
rat
lethal concentration (50 percent kill): 33,500 mg/m3/4 hour N/R 85GMAT -,53,1982
inhalation
rat
lowest published toxic concentration: 0.5 pph/2 hour Behavioral: Food intake (animal)

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
VCVGK* -,286,1994
intravenous
mouse
lethal dose (50 percent kill): 150 mg/kg N/R USXXAM #4168308
oral
mammal (species unspecified)
lethal dose (50 percent kill): 3,600 mg/kg Behavioral: Antipsychotic GTPZAB 24(4),55,1980
oral
rat
lethal dose (50 percent kill): 3.6 mg/kg N/R VCVGK* -,286,1994


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
inhalation
mouse
lowest published toxic concentration: 48,600 mg/m3/4 hour/30 day- intermittent Lung, Thorax, or Respiration: Other changes

Liver: Other changes

Endocrine: Adrenal cortex hyperplasia
VCVGK* -,286,1994
inhalation
rat
lowest published toxic concentration: 50 ppm/24 hour/14 week- continuous Liver: Changes in liver weight

Kidney, Ureter, and Bladder: Other changes in urine composition

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
APTOA6 57,176,1985
inhalation
rat
lowest published toxic concentration: 48,600 mg/m3/4 hour/30 day- intermittent Liver: Other changes FATOAO 35,271,1972
inhalation
rat
lowest published toxic concentration: 1,100 mg/m3/60 day- intermittent Brain and Coverings: Other degenerative changes

Lung, Thorax, or Respiration: Other changes

Kidney, Ureter, and Bladder: Other changes
VCVGK* -,286,1994


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

International Agency for Research on Cancer (IARC) Cancer Review Animal Inadequate Evidence IMSUDL 7,93,1987
TOXICOLOGY REVIEW
ARPTDI 16,67,1976
TOXICOLOGY REVIEW
KDYIA5 10,82,1976
TOXICOLOGY REVIEW
CANJAE 19,152,1972
TOXICOLOGY REVIEW
ARMCAH 25,411,1974
TOXICOLOGY REVIEW
AACRAT 57,328,1978
TOXICOLOGY REVIEW
TPHSDY 23,519,2002
TOXICOLOGY REVIEW
AINCM* 7,63,2006
TOXICOLOGY REVIEW
DIMON* 39,678,1993
TOXICOLOGY REVIEW
HUTOX* -,577,1996


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

Occupational Exposure Limit - DENMARK time-weighted average 2 ppm (14 mg/m3), OCT 2002
Occupational Exposure Limit - RUSSIA short term exposure limit 200 mg/m3, JUN2003


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO METHOXYFLURANE-air ceiling concentration 2 ppm NIOSH* DHHS #92-100,1992
National Occupational Hazard Survey 1974 National Occupational Hazard Survey 1974: Hazard Code: 82904;
Number of Industries 2;
Total Number of Facilities 627;
Number of Occupations 6;
Total Number of Employees Exposed 8,095
National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: 82904;
Number of Industries 2;
Total Number of Facilities 2,120;
Number of Occupations 14;
Total Number of Employees Exposed 32,772;
Total Number of Female Employees Exposed 18,210


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse
EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test
EPA TSCA Section 8(d) unpublished health/safety studies
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001


REFERENCES:

CODEN
REFERENCE

85GMAT "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982
AACRAT Anesthesia and Analgesia (New York). (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.36- 1957-
AINCM* Anaesthesia and Intensive Care Medicine (Abingdon: Medicine Pub. Co.) V.1- 2000-
ANESAV Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1940-
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH
ARMCAH Annual Review of Medicine. (Annual Reviews, Inc., POB 10139, Palo Alto, CA 94303) V.1- 1950-
ARPTDI Annual Review of Pharmacology and Toxicology. (Annual Reviews, Inc., POB 10139, Palo Alto, CA 94303) V.16- 1976-
CANJAE Canadian Anaesthetists' Society Journal. (Toronto, Ont., Canada) V.1-33, 1954-86.
DIMON* Disease-a Month (Chicago : Year Book Publishers) V. 24- 1978-
ENVRAL Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967-
EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945-
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87.
GTPZAB Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI
HUTOX*
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979-
KDYIA5 Kidney International. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus Secaucus, NJ 07094) V.1- 1972-
NIOSH* National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda.
TPHSDY Trends in Pharmacological Sciences. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1979-
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
VCVGK* "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994.

FDA-proprietary drug

RTECS Compound Description:
   Tumorigen
   Drug
   Mutagen
   Reproductive Effector
   Human Data
   Primary Irritant

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us